Antimicrobial Stewardship Strategies, Measures and Quality Improvement During COVID-19: The Role of Pharmacist

Research output: Contribution to conferencePosterpeer-review


This research delves into Antimicrobial Stewardship (AMS) strategies and quality improvement measures in acute-care hospitals during the COVID-19 pandemic, with a focus on the role of pharmacists. It examines how the pandemic heightened the threat of Antimicrobial Resistance (AMR) and the necessity of effective AMS implementation. Conducting a systematic literature search from 2007 to March 2021 using the PRISMA 2020 flowchart, the study aims to evaluate the effectiveness of various AMS strategies and measures. The research underscores the significant contribution of pharmacists and the need for their expanded roles in AMS during pandemics like COVID-19, offering crucial insights for healthcare improvement.
Original languageEnglish
Number of pages1
Publication statusPublished - 10 Nov 2021
EventSaudi Society of Clinical Pharmacy: SSCP General Assembly Meeting 2021 - Riyadh, Saudi Arabia
Duration: 10 Nov 202112 Nov 2021
Conference number: 1


ConferenceSaudi Society of Clinical Pharmacy
Abbreviated titleSSCP 2021
Country/TerritorySaudi Arabia
Internet address


  • antimicrobial
  • antimicrobial stewardship
  • Quality Improvement
  • Indicators
  • strategies and measures
  • antimicrobial resistance
  • Antibiotic Prescribing
  • Antibiotic safety
  • Pharmacist role
  • Clinical pharmacist
  • pharmacy
  • hospitals
  • Acute care setting
  • Secondary Care
  • multidisciplinary
  • Pharmaceutical care


Dive into the research topics of 'Antimicrobial Stewardship Strategies, Measures and Quality Improvement During COVID-19: The Role of Pharmacist'. Together they form a unique fingerprint.

Cite this